Interferons beta have vasoconstrictive and procoagulant effects: A woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis
Authors:
- Uroš RotURUroš Rot
- Alenka Horvat LedinekALAlenka Horvat Ledinek
- 1 December 2013
- journal article
- case report
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 115, S79-S81
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Arterial hypertension induced by interferon beta 1b in a patient with multiple sclerosisMultiple Sclerosis Journal, 2012
- Adverse Events of Interferon Beta-1a: A Prospective Multi-Centre International ICH-GCP-Based CRO-Supported External Validation Study in Daily PracticePLOS ONE, 2011
- Sildenafil Therapy for Interferon-β-1a-Induced Pulmonary Arterial Hypertension: A Case ReportCardiology, 2011
- Type I interferon system activation and association with disease manifestations in systemic sclerosisAnnals of the Rheumatic Diseases, 2010
- Livedo reticularis tras inyección subcutánea de interferón beta-1bRevista De Neurologia, 2010
- Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case reportMultiple Sclerosis Journal, 2009
- Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]Neurology, 2002
- Multiple sclerosisNeurology, 1999
- Interferon-α elevates pulmonary blood pressure in sheep—the role of thromboxane cascadeEuropean Journal of Pharmacology, 1999
- Severe Raynaud's phenomenon associated with interferon-β treatment for multiple sclerosisThe Lancet, 1998